Therefore, immunohistochemistry (IHC) is necessary to confirm the tumor’s endothelial origin, with markers like CD31, CD34, FLI1, and ERG being particularly useful for identifying vascular differentiation (Figure 4) [4,12]. The gene discussed is FLI1; the disease is neoplasm.